ID   GIBHi002-A-4
AC   CVCL_ZE04
SY   C11-LRRK2-KO2
DR   hPSCreg; GIBHi002-A-4
DR   SKIP; SKIP005740
DR   Wikidata; Q98126371
RX   PubMed=32339904;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 18618; LRRK2.
CC   Derived from sampling site: Urine.
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_YC25 ! GIBHi002-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 12-01-21; Version: 3
//
RX   PubMed=32339904; DOI=10.1016/j.scr.2020.101804;
RA   Chen S.-C., Luo Z.-W., Ward C., Ibanez D.P., Liu H., Zhong X.-F.,
RA   Sharma N.K., Qin B.-M., Fan W.-X., Wang D.-Y.;
RT   "Generation of two LRRK2 homozygous knockout human induced pluripotent
RT   stem cell lines using CRISPR/Cas9.";
RL   Stem Cell Res. 45:101804-101804(2020).
//